At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06872 TENNOR THERAP-B
Trading 07-03 11:41:34
198.600
-1.400
-0.70%
High204.800
Low194.300
Vol41.80K
Open200.200
D1 Closing200.000
Amplitude5.25%
Mkt Cap10.39B
Tradable Cap10.39B
Total Shares52.33M
T/O8.33M
T/O Rate0.08%
Tradable Shares52.33M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
TenNor Therapeutics secures 100% shareholder backing for all six AGM resolutions
Tennor Therapeutics (Suzhou) Ltd is a China-based company primarily engaged in the discovery and development of innovative drug products. The Company focuses on the fields of bacterial infections and bacterial metabolism diseases. The Company's products include Rifasutenizol (TNP-2198), a novel molecular entity candidate for the treatment of Helicobacter pylori, Rifaquizinone (TNP-2092) injection, a triple-targeting antibacterial drug candidate for the treatment of implant-associated bacterial infections and TNP-2092 oral, multi-targeting antibacterial drug candidate for the treatment of diseases associated with gut bacterial metabolism.